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Summary: A new case of 3-hydroxyacyl-CoA dehydrogenase d ficiency is 
described with a relatively benign course. 
3-Hydroxyacyl-CoA dehydrogenase (HAD) deficiency (EC 1.1.1.35) as a cause of 3- 
hydroxydicarboxylicaciduria has been suspected in approximately 30cases (Riudor 
et al., 1986; Kelley and Morton, 1988; Poll-The et al., 1988; Hale and Thorpe, 1989; 
Wanders et al., 1989; Dionisi Vici et al., 1990; Hagenfeldt et al., 1990; Hale et al., 
1990; Pollitt, 1990). A reduction in activity of the long-chain HAD in fibroblast 
homogenates has been proved in 6 cases (Wanders et al., 1989; Dionisi Vici et al., 
1990; Hale et al., 1990; Rocchiccioli et al., 1990). In one patient a reduction in the 
activity of short-chain HAD has been found (Hale and Thorpe, 1989). We report on 
a seventh patient with a proven defect of long-chain HAD, who is now 10 years old 
and shows, in contrast to most other suspected or proven cases, a relatively benign 
clinical course. 
CASE REPORT 
The patient was born in 1980 as the second child of apparently healthy unrelated 
parents. Her brother is healthy. Her mother admits to mild symptoms suggestive of 
hypoglycaemia, but this has never been severe nough to request medical investigation. 
The patient was born after a normal pregnancy of 40 weeks with a weight of 3250 g 
and a length of 47 cm. At the age of 6 months developmental arrest was noted 
following a period of increasing feeding problems with vomiting, sweating and 
hypotonia. 
On admittance tothe hospital at the age of 6.5 months he was a passive hypotonic 
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child who could not hold up her head, could not turn around and cried weakly. Her 
weight was below the 3rd centile, her length between the 25th and 50th centile and 
her head circumference on the 10th centile. Reflexes were no mal as were an EMG 
and EEG. An ECG was normal, an echocardiogram showed, except fora small atrial 
septal defect, no abnormalities. Radiography ofthe head, spine and hand was normal. 
Blood glucose after a 13h fast was 2.0mmol/L, blood pH was 7.38, base excess 
-5.0 mmol/L, standard bicarbonate 20 mmol/L. Blood creatinine, lactate, pyruvate, 
3-hydroxybutyrate, acetoacetate, hyroid hormones, and cerebrospinal fluid were 
normal. Free carnitine in plasma was 18.5 #mol/L (normal > 25). 
The clinical and chemical findings in connection with the urinary organic acid 
profile (see results) suggested very strongly that the cause of her disease was a defect 
in the/3-oxidation f fatty acids but was not medium-chain acyl-CoA dehydrogenase 
deficiency. Therefore, she was given a diet rich in carbohydrates (75% of the calories) 
and poor in fat (7 %), which resulted in a rapid recovery, weight gain, and normalization 
of muscle tone and of psychomotor development. She did very well on a high- 
calorie/high-carbohydrate intake spread over the day with a nocturnal meal at 
midnight, 0.00 h. 
Uncooked starch was tried with a satisfactory esult but was not tolerated for any 
length of time. As he was becoming rather obese owing to the diet she was tarted 
on gradual reduction of the carbohydrate intake, and L-carnitine 330rag twice per 
day was added, because of consistently low plasma carnitine levels. During an 
observation period of 9 years there have been three episodes of hypoglycaemia 
necessitating hospital admittance, twice in association with gastroenteritis and once 
after physical exhaustion during a skiing vacation. 
At the age of 10 years her length is on the 75th centile, her weight on the 50th 
centile, and her head circumference on the 60th centile. She is a beautiful sportive 
girl of normal intelligence. She still takes a nocturnal meal and uses a normocatoric, 
mildly fat-restricted and carbohydrate-enriched di t plus extra carnitine. There are 
signs of mild exercise intolerance. There are no indications of cardiac involvement 
by electrocardiography and echocardiography. 
However, recently she showed signs of visual deterioration, namely decreased night 
vision, photophobia and constriction of the visual field. On fundoscopy the optic 
discs are somewhat pale with narrow vessels. There are diffuse pigmentary disturbances 
at the posterior pole and some pigmentations i  the periphery. The electrooculogram 
shows normal potentials at rest and abnormally low responses to light. The 
electroretinogram gives diminished amplitudes (30-40%) for both rods and cones. 
METHODS 
Organic acids in the urine were determined and identified by capillary" GC--MS 
(Jakobs et al., 1981). 
Leukocytes (and platelets) were isolated from blood samples from the patient and 
from control subjects with EDTA as an anticoagulant (Wanders et al., 1986a). 
Oxidation of octanoate and palmitate was measured in isolated leukocytes by 
measuring the release of 14CO2 and t4C-radiolabelled water-soluble products from 
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[1-14C]octanoate and [1-14C]palmitate, r spectively. Leukocytes were incubated for 
60 min at 37°C in a medium containing phosphate-buffered saline plus 200/~mol [I- 
~4C]octanoate or [1-~4C]palmitate. T rmination of the reaction and quantification 
of 14CO 2 and 14C-radiolabelled water-soluble products was as described previously 
(Wanders et al., 1986b). 
The activity of HAD in fibroblast homogenate was measured as described 
elsewhere (Wanders et aL, 1990) in a medium containing 50 mmol 2-(N-morpholino)- 
ethanesulphonic acid (MES), 100 mmol potassium phosphate, 0.1 mmol dithiothreitol, 
0.1% (w/v) Triton X-100, 100/~mol NADH (final pH 6.16). Reactions were started 
by adding the 3-oxoacyl-CoA ester at a final concentration f 25 pmol/L. 
RESULTS 
The urinary organic acid concentrations were raised and the profile (Table 1) was 
characteristic with C6-C 12 saturated and unsaturated (A)dicarboxylic acids and with 
3-hydroxy saturated and unsaturated dicarboxylic acids with 6 to 14 carbon atoms. 
The ratio of 3-hydroxyadipic over adipic acid was 2.25 and the ratio of total 3- 
hydroxydicarboxylic over dicarboxylic acids was 2.07. There were negligible amounts 
of 3-hydroxybutyrate nd some 5-hydroxyhexanoate. Glycine conjugates were not 
present. 
The results of the oxidation of octanoate and palmitate in leukocytes are given in 
Table 2: there is a normal oxidation of octanoate and a decrease in palmitate 
oxidation giving rise to an abnormally low ratio of CI6/Cs oxidation. 
The activity of HAD in homogenates of cultured fibroblasts was measured with 
three different substrates (Table 3). There is normal activity with acetoacetyl-CoA 
and a decreased activity especially with 3-ketopalmitoyl-CoA. This means that there 
is normal activity of the short-chain HAD and a decrease of the long-chain HAD 
Table 1 Organic acids in a urine sample when the patient was 7 months old [#mol/mmol 
creatinine] 
Lactic 39 Adipic 474 
Pyruvic 29 3-Hydroxyadipic 1066 
3-Hydroxybutyric 11 A2-Adipic 37 
5-Hydroxyhexanoic 36 A3-Adipic 7 
Suberic 120 Sebacic 97 
3-Hydroxysuberic 26 3-Hydroxysebacic 228 
Aa-Suberic 43 A3-Sebacic 42 
3-Hydroxy-A-suberic 44 A4-Sebacic 56 
3-Hydroxy-A-Sebacic 72 
3-Hydroxy-C12-dioic 89 3-Hydroxy-C~4-dioic 19 
3-Hydroxy-A-C12-dioic 58 3-Hydroxy-A-C~4-dioic 35 
3-Hydroxy-A,A-C 12-dioic 4 
Ratio, 3 -hydroxy-adipic/adipic 2.25 
Ratio, 3-hydroxydicarboxylic/dicarboxylic 2.07 
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Table 2 fl-Oxidation activity [#moib- 1 (mg protein)- 1] in 
ieukocytes of the patient and of controls 
Octanoate Palmitate C16/C8 ratio 
Controls ~ 3.64-3.96 (4) 2.58-2.84 ( ) 0.71-0.74 
Patient 3.55/3.83 1.58/1.72 0.45 
aNumbers ofindividuals tested in parentheses 
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Table 3 3-Hydroxyacyl-CoA dehydrogenase activity with 
three different substrates in cultured skin fibroblasts f the 
patient [nmol rain-1 (rag protein)-1] 
Controls* 
Patient (mean _+ SD) 
Acetoacetyl-CoA 
3-Ketooctanoyl-CoA 
3-Ketohexadecanoyt-CoA 
(3-Ketopalmitoyl-CoA) 
C8/C4 activity ratio 
C16/C4 activity ratio 
113.6 117 +_ 18.1 (13) 
28.7 59.1 _+ 9.2 (13) 
21.9 83.9 ± 11.9 (13) 
0.25 0.53 + 0.07 (13) 
0.19 0.75 + 0.09 (13) 
* Numbers of individuals tested in parentheses 
activity (25% of the normal mean), which is also apparent in a 75% reduction in the 
ratio of the activities with ketopalmitoyl-CoA over acetoacetyl-CoA. 
DISCUSSION 
An increase in the urinary excretion of 3-hydroxydicarboxylic acids can occur as a 
consequence of a defective HAD but can also be a feature of other inherited or 
acquired diseases, e.g. Reye syndrome, ketoacidosis, severe progressive hepatic 
cirrhosis, medium-chain acyl-CoA dehydrogenase deficiency, generalized peroxisomal 
dysfunction (for differential diagnosis ee Pollitt, 1990) and possibly a long-chain 
ketoacyl-CoA thiolase deficiency (Ribes et al., 1989). Most of these conditions 
show, in addition, other typical metabolites and clinical features, and the ratio of 
hydroxydicarboxylic acids to dicarboxylic acids will be less than unity. 
The lack of enzymatic onfirmation of the presumptive diagnosis of long-chain 
HAD deficiency in many of the cases discussed below at present leaves uncertainties 
about the obligatory nature of some of the reported symptoms. 
3-Hydroxydicarboxylic aciduria due to long-chain HAD deficiency is very similar 
in its acute symptoms to other defects of mitochondrial//-oxidation of fatty acids 
like long- and medium-chain acyl-CoA dehydrogenase d ficiencies. Unlike the latter, 
however, the prognosis regarding survival and response to treatment appears to be 
very bad according to the literature. 
Of 25 patients reported with presumed or proven long-chain HAD-deficiency, 17 
died during an acute attack either before therapy or despite therapy (Dionisi Vici et 
J. lnher. Metab. Dis. 14(1991) 
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al., 1990; Hagenfeldt et al., 1990, Pollitt, 1990; Rocchiccioli et al., 1990). As a rule, 
the disease became manifest in the first months of life with symptoms resembling 
Reye syndrome. Repeated acute episodes are quite typical, often triggered by upper 
respiratory or gastrointestinal infections. 
There were reports on 10 siblings of patients who had died earlier during similar 
crises with diagnosis of 'sudden infant death syndrome' or Reye syndrome (Hagenfeldt 
et at., 1990; Wanders et at., 1990; Pollitt, 1990). One of those siblings died on the 
third day of life (Wanders et al., 1990). In the two siblings who had died before their 
respective index cases the presumptive diagnosis of 3-hydroxydicarboxylic aciduria 
could be confirmed retrospectively b the demonstration f measurable concentrations 
of 3-hydroxy fatty acids of chain lengths between 6 and 10 carbon atoms and up to 
18 carbon atoms in filter-paper blood samples obtained for neonatal screening and 
stored for up to 6 years (Von D6beln et al., 1990). 
Progressive or intermittent pathological change in liver with fatty infiltration and 
fibrosis or cirrhosis was found in at least 14 patients (Riudor et al., 1986; Poll-The 
et al., 1988; Hagenfeldt et aI., 1990; Hale et aI., 1990; Pollitt, 1990; Rocchiccioli et al., 
1990). This was not the case in our patient. 
As in other defects of fatty acid oxidation, most patients showed episodic 
hypoketotic hypoglycaemia with intolerance to fasting and secondary carnitine 
deficiency. Free and total carnitine was decreased in the plasma of a number of 
patients as well as in our patient and, in addition, was found to be low in a muscle 
and liver biopsy of one patient concomitantly with an increase of long-chain 
acylcarnitines (Hate et al., 1990). Primary (systemic) carnitine deficiency was the 
presumptive diagnosis in our patient before the identification of the 3-hydroxy fatty 
and dicarboxylic acids in urine. Muscular hypotonia and motor developmental 
retardation seemed to fit this diagnosis. 
Unlike many patients in the literature, our patient's ubsequent mental and motor 
development was normal. There were only three further mild attacks of metabolic 
dysregulation. This is most probably due to the very strict avoidance of hypoglycaemia 
and catabolism over all her years. 
Signs of myopathy or cardiomyopathy (Ruidor et al., 1986; Dionisi Vici et al., 
1990; Rocchiccioli et al., 1990) have not been found in this patient. Neither could 
peripheral neuropathy be demonstrated. This was a prominent finding in four other 
cases (Poll-The et al., 1988; Dionisi Vici et al., 1990). 
Until recently our patient appeared to be similar to one patient reported by Pollitt 
(1990), who after one first attack of a Reye syndrome-like picture was normal. When 
she was treated with a carbohydrate-enriched dietin frequent meals with a nocturnal 
fasting period of less than 7 h plus extra L-carnitine, we were no longer able to find 
the abnormal 3-hydroxy acids in her urine. 
The demonstration of a retinal pigment dystrophy, which has been found in four 
other patients (Riudor et at., 1986; Poll-The et aI., 1988; Dionisi Vici et aI., 1990), 
however, will necessitate careful follow-up of this patient. Especially in view of the 
favourable course of her disease and of the absence of chemical indices for metabolic 
derangement, i  is a disturbing thought that this serious complication has arisen, 
perhaps as an obligatory long-term consequence of the metabolic defect. 
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BOOK REVIEW 
Techniques in Diagnostic Human Biochemical Genetics - a laboratory manual. Edited 
by F. A. Hommes. Wiley-Liss, New York, 1991. ISBN 0-471-56076-6, 60 pp., $69.50. 
Few books deal with the techniques required for the diagnosis of biochemical genetic 
disorders. Most methods are developed within specialist laboratories, often finely 
tuned to individual needs and not always well documented. This book was produced 
as a result of a programme of proficiency testing in North American laboratories 
that provide a diagnostic service in biochemical genetics. The book contains 33 
chapters, written by well-established authorities, with special emphasis on the handling 
and interpretation of results. Opening chapters are on laboratory organization, 
statistics, data management and transmission of results, followed by a useful chapter 
on general metabolic screening. The next twenty chapters deal with analysis of non- 
protein metabolites - such as sugars, gtycosaminoglycans, amino acids, phenylalanine 
and tyrosine, organic acids (an excellent reference source on GS-MS), very-long- 
chain fatty acids, phytanic acid, pipecolic acid, urinary oligosaccharides, sialic acid, 
tissue gangliosides and glycosphingolipids, galactose metabolites and associated 
enzymes, as well as a useful chapter on lactate/pyruvate and ketone bodies. Chapters 
follow on carnitine, porphyrins, orotate, oxalate, pterins, purines and pyrimidines. 
The last eight chapters address defects manifest in proteins such as those in 
lipoproteins, el-antitrypsin and haemoglobins, aswell as screening of maternal serum 
e-fetoprotein. Finally there is a short chapter on biotinidase followed by one on 
radiometric assay of enzymes associated with mucopolysaccharidoses with the last 
chapter on other lysosomal enzymes often assayed for screening. 
There is no doubt that this book will find a useful place on the laboratory bench 
rather than the library shelf. It contains a wealth of useful information, although 
different laboratories will regret the omission of subjects uch as the glycogenoses, 
cell culture techniques and use of these cells in oxidation and other studies. This 
book nevertheless represents good value for money and is clearly to be recommended 
to all involved in the diagnosis of metabolic disease at the biochemical level. 
G. T. N. Besley 
Top Grade Biochemist 
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